skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Influence of natural and recombinant interferons on development of antiviral condition and activity of natural killers

Journal Article · · Dokl. Biol. Sci. (Engl. Transl.); (United States)
OSTI ID:5856242

For the purpose of a preliminary estimate of the therapeutic potential of domestic recombinant alpha/sub 2/-component of human leukocytic interferon (rl) in vitro tests, the authors studied its ability to induce development of antiviral condition in diploid culture of human embryo fibroblasts and to activate the cytolytic effect of natural killers in relation to tumor cells, of the K-562 leukemia line and cells of lung adenocarcinoma. The authors used a medicinal form of rL which was derived by expression of a reconstructed gene in Escherichia coli cells. Part of the tests were conducted with an analogous preparation synthesized using another producer, Pseudomonas sp). The biological effect of both preparations was the same. For comparison, a natural preparation was used in all tests: human leukocytic interferon for injection, II(le). The authors studied activity of natural killers in a fraction of mononuclears isolated from blood of essentially healthy donors and from cancer patients. Cells were incubated for 2 h with various concentrations of interferons, then combined in a ratio of 25-50:1 with target cells labeled with /sup 51/Cr. Cytotoxic reaction was conducted for 4 (4-CTR) or 18 h (18-CTR) at 37/sup 0/C. Natural killers could thus be divided into two subpopulations: killer (4-CTR) and cytotoxic (18-CTR) cells. In preliminary tests, both preparations possessed the ability to active natural killers. The effective concentration for rL was within the limits of 1000-2000 IU/ml, and 50-200 Iu/ml for Le. The data on activation of natural killers in 16 oncological patients (primarily with lung cancer), the authors established that both rL and Le induced activation of natural killers in the overwhelming majority of cases in relation to K-562 target cells and adenocarcinomas of the lung.

Research Organization:
N. F. Gamalei Scientific-Research Institute of Epidemiology and Microbiology, Moscow, USSR
OSTI ID:
5856242
Journal Information:
Dokl. Biol. Sci. (Engl. Transl.); (United States), Vol. 284:1-6; Other Information: Translated from Dokl. Akad. Nauk SSSR; 284: No. 6, 1514-1516(Oct 1985)
Country of Publication:
United States
Language:
English

Similar Records

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes
Journal Article · Tue Jun 01 00:00:00 EDT 1982 · J. Exp. Med.; (United States) · OSTI ID:5856242

Human leukocyte interferon as part of a combined treatment for previously untreated small cell lung cancer
Journal Article · Fri Feb 01 00:00:00 EST 1985 · J. Biol. Response Modif.; (United States) · OSTI ID:5856242

Regulation of IL-2 induced proliferation and cytotoxicity in human natural killer cells by monoclonal antibodies
Conference · Wed Mar 05 00:00:00 EST 1986 · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) · OSTI ID:5856242